Portal de investigación
- Inicio
- Proyectos y Estudios
- DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) T790M MUTATION BY ULTRASENSITIVE PCR ASSAY BEFORE TREATMENT WITH TYROSINE-KINASE INHIBITORS (TKI) AND ASSESSMENT OF THE ROLE OF T790M MUTATION TO PREDICT RESISTANCE MECHANISM AT PROGRESSION IN STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) T790M MUTATION BY ULTRASENSITIVE PCR ASSAY BEFORE TREATMENT WITH TYROSINE-KINASE INHIBITORS (TKI) AND ASSESSMENT OF THE ROLE OF T790M MUTATION TO PREDICT RESISTANCE MECHANISM AT PROGRESSION IN STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
Datos básicos
Objetivos del proyecto
Observaciones: Estado Comité: APROBADO CEIm
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
BIOMARKERS & PRECISION MEDICINE UNIT. RESEARCH HEALTH INSTITUTE HOSPITAL LA FE
Cita
DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) T790M MUTATION BY ULTRASENSITIVE PCR ASSAY BEFORE TREATMENT WITH TYROSINE-KINASE INHIBITORS (TKI) AND ASSESSMENT OF THE ROLE OF T790M MUTATION TO PREDICT RESISTANCE MECHANISM AT PROGRESSION IN STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS. (UBF-ITK-2017-01). BIOMARKERS & PRECISION MEDICINE UNIT. RESEARCH HEALTH INSTITUTE HOSPITAL LA FE. -2018. IP:ÓSCAR JOSÉ JUAN VIDAL.